- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05562856
Clinical Evaluation of White Spot Lesions Treated by S-PRG Material and Composite Sealants in Comparison With ICON
September 30, 2022 updated by: Eslam Gabr, Al-Azhar University
Clinical Evaluation of White Spot Lesions Treated by Surface Pre-reacted Glass Filler Coating Material and Composite Sealants in Comparison With Icon Resin Infiltration by Using Laser Fluorescence and Spectrophotometer
Dental caries is the primary cause of tooth loss and oral diseases.
Dental decay is a continuous pathological process with loss of tooth minerals, demineralization, which involves the destruction of tooth structure from acids.
The first sign of early active demineralization is white spot lesions (WSLs) on the tooth surface, meanwhile, subsurface active mineral decomposition.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Deposition of minerals depends on the equilibrium between demineralization and remineralization which may happen as a natural repair mechanism.
The aim of this trial is to comparatively evaluate the efficacy of surface pre-reacted glass filler (S-PRG) Barrier Coat coating material against the Icon resin infiltration in the ability to improve the caries lesion state of the WSLs along 1 year.
Laser fluorescence was used to compare the two materials to evaluate the caries progression.
PRG Barrier Coat group showed immediate significant improvement in LF scores in demineralization progress and inhibition of caries progression with a significant improved effect.
S-PRG Barrier Coat was clinically successful strategy in inhibition of caries and improve remineralization.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt, 11768
- Mohamed Wakwak
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients within 20-40 years of age.
- Each patient has 4 or more WSLs.
- Mild and moderate WSLs according to Gorelick's scale.
- Good oral hygiene and willing patients who can attend the study visits.
- a Symmetrical number of permanent teeth in each arch (mesial to second molars).
Exclusion Criteria:
- Active carious lesions.
- Facial surface restorations.
- Intrinsic and extrinsic stains.
- Patients who have a significant medical history or if they smoke.
- Criteria for discontinuation; Mortality and acquiring severe debilitating disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: surface pre-reacted glass filler coating material
surface pre-reacted glass filler coating material used to remineralize WSLs
|
the ability to improve the aesthetic appearance (masking) and caries lesion state of the WSLs
|
Active Comparator: micro-invasive resin infiltration technique (Icon)
micro-invasive resin infiltration technique (Icon) in the ability to improve caries lesion state (LF scores) and making the WSLs
|
the ability to improve the aesthetic appearance (masking) and caries lesion state of the WSLs
|
Experimental: Permaseal resin
Permaseal composite resin sealant as micro-invasive resin infiltration technique in the ability to improve caries lesion state (LF scores) and making the WSLs
|
the ability to improve the aesthetic appearance (masking) and caries lesion state of the WSLs
|
Experimental: Optiguard resin
Optiguardcomposite resin sealant as micro-invasive resin infiltration technique in the ability to improve caries lesion state (LF scores) and making the WSLs
|
the ability to improve the aesthetic appearance (masking) and caries lesion state of the WSLs
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessments of caries lesion state of WSLs:
Time Frame: 1 year
|
Assessing of carious lesions state of WSLs, was performed by using Diagnodent pen to record the progression or regression of caries by time.
The assessment of the WSLs demineralization condition took place before intervention (baseline) [T0], immediately after intervention [T1], 3 months later [T2] ,6 months later [T3] and 1 year later [T4].
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of color change of WSLs:
Time Frame: 1 year
|
The difference in color of the WSLs were performed by Vita Easyshade V at the five distinct times: before intervention (baseline) [T0], immediately after intervention [T1], 3 months later [T2] ,6 months later [T3] and 1 year later [T4].
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Khalid Noman, PROF, Alazhar Univerisity
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 20, 2020
Primary Completion (Actual)
December 2, 2021
Study Completion (Actual)
December 3, 2021
Study Registration Dates
First Submitted
September 16, 2022
First Submitted That Met QC Criteria
September 28, 2022
First Posted (Actual)
October 3, 2022
Study Record Updates
Last Update Posted (Actual)
October 4, 2022
Last Update Submitted That Met QC Criteria
September 30, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 350/466/08/10/19
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on White Spot Lesions
-
3MUniversity of Tennessee Health Science CenterCompleted
-
Ege UniversityCompletedWhite Spot LesionsTurkey
-
University of DundeeNHS TaysideCompletedOrthodontic Treatment | Demineralisation | White Spot LesionsUnited Kingdom
-
Cairo UniversityNot yet recruitingWhite Spot Lesions
-
Cairo UniversityUnknown
-
Medical University of WarsawCompletedCaries | White Spot LesionsPoland
-
Gaba International AGPD Dr. Christian HeumannCompletedTooth; Lesion, White Spot LesionsGermany
-
Ain Shams UniversityNot yet recruiting
-
Universidade Federal de Santa MariaUnknownTooth; Lesion, White Spot LesionsBrazil
Clinical Trials on surface pre-reacted glass filler coating material
-
Kritirat KiatsiriroteUniversity of WashingtonCompleted
-
Cairo UniversityNot yet recruitingDentin Hypersensitivity, Non-carious Cervical Lesions, Bioactive Glass Air Polishing, S-PRG
-
Cairo UniversityNot yet recruitingCaries, Dental | Remineralization | White Spot Lesion
-
Western University of Health SciencesHoya Cooperation Vision CareCompleted
-
University of Milano BicoccaHOYA Corporation Vision CareCompleted
-
Cairo UniversityUnknown